Bis(2-ethylhexyl) phthalate (DEHP) is used in the production of polyvinyl chloride (PVC). It exhibits low toxicity from acute (short-term) and chronic (long-term) exposures. Acute exposure to large oral doses of DEHP can cause gastrointestinal distress in humans. No information is available on the chronic, reproductive, developmental, or carcinogenic effects of DEHP in humans. Animal studies have reported increased lung weights and increased liver weights from chronic inhalation exposure to DEHP. Oral exposure has resulted in developmental and reproductive effects in rats and mice. A study by the National Toxicology Program (NTP) showed that DEHP administered orally increased the incidence of liver tumors in rats and mice. EPA has classified DEHP as a Group B2, probable human carcinogen Please Note: The main sources of information for this fact sheet are EPA's Integrated Risk Information System (IRIS) (3), which contains information on oral chronic toxicity and the Reference Dose (RfD), and the carcinogenic effects of DEHP including the unit cancer risk for oral exposure, and the Agency for Toxic Substances and Disease Registry's (ATSDR's)Toxicological Profile for Bis(2-ethylhexyl)phthalate. (1)
Uses
The major use of DEHP is in the production of PVC and vinyl chloride resins, where it is added to plastics to make them flexible. (1) Sources and Potential Exposure
The most probable route of exposure to DEHP is through food, with an average contribution of DEHP from food of 0.25 milligrams per day (mg/d). DEHP migrates into food from plastics during processing and storage. (1) Exposure to DEHP can also occur during certain medical procedures, such as blood transfusions and kidney dialysis and use of respirators. (1) In one study, DEHP was found in drinking water, at levels ranging from 0.04 to 30 parts per billion (ppb).
(1) The average ambient air concentration of DEHP is very low, with < 0.002 ppb in urban areas. DEHP levels in indoor air in a newly painted room or a room with recently installed flooring could be higher than levels in the outdoor air. (1) Occupational exposure to DEHP may occur for those workers in factories that manufacture or use the chemical. (1) Assessing Personal Exposure Breakdown products of DEHP may be measured in urine or blood to determine exposure to DEHP. However, this test only provides a measure of recent exposure to the chemical. (1) No information is available on the acute effects of DEHP in humans via inhalation exposure. (1) Acute exposure to large oral doses of DEHP (5 to 10 grams) can cause gastrointestinal distress in humans. , that is likely to be without appreciable risk of deleterious noncancer effects during a lifetime. It is not a direct estimator of risk but rather a reference point to gauge the potential effects. At exposures increasingly greater than the RfD, the potential for adverse health effects increases. Lifetime exposure above the RfD does not imply that an adverse health effect would necessarily occur. (3) EPA has medium confidence in the study on which the RfD was based because it utilized sufficient numbers of guinea pigs and measured multiple endpoints but only used two dose levels; medium confidence in the database because there are corroborating chronic animal bioassays; and, consequently, medium confidence in the RfD. DEHP has been demonstrated to cause developmental toxicity, such as birth defects, in rats and mice from oral exposure. Reproductive effects, such as decreased fertility, proportion of pups born alive, and testicular weights and tubular atrophy, have also been noted from oral exposure to DEHP in animals. (1) Cancer Risk: No information is available on the carcinogenic effects of DEHP in humans. (1) In the only available animal inhalation cancer study, lifetime exposure of hamsters to a very low dose of DEHP did not result in any significant increase in the incidence of tumors. However, because this is a very low dose, it is not possible to reach a conclusion as to whether or not higher concentrations might produce different results. (1) A study by the NTP showed that DEHP administered in the diet increased the incidence of liver tumors in rats and mice. Health Data from Inhalation Exposure ACGIH TLV --American Conference of Governmental and Industrial Hygienists' threshold limit value expressed as a ACGIH TLV --American Conference of Governmental and Industrial Hygienists' threshold limit value expressed as a time-weighted average; the concentration of a substance to which most workers can be exposed without adverse effect. NIOSH IDLH --National Institute of Occupational Safety and Health immediately dangerous to life and health; NIOSH concentration representing the maximum level of a pollutant from which an individual could escape within 30 minutes without escape-impairing symptoms or irreversible health effects. NIOSH REL --NIOSH's recommended exposure limit; NIOSH-recommended exposure limit for an 8-or 10-h timeweighted-average exposure and/or ceiling. NIOSH STEL --NIOSH's recommended short-term exposure limit; a 15-minute TWA exposure which should not be exceeded at any time during a workday. OSHA PEL --Occupational Safety and Health Administration's permissible exposure limit expressed as a timeweighted average; the concentration of a substance to which most workers can be exposed without adverse effect averaged over a normal 8-h workday or a 40-h workweek. 
